Jiangsu Hualan Stock Soars 7.64%, Hits Intraday High of CNY 140.95

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. has experienced significant activity today, with the stock rising by 7.64% and reaching an intraday high of CNY 140.95. This performance stands in contrast to the China Shanghai Composite, which saw a modest increase of 0.5% on the same day. Over the past week, Jiangsu Hualan has shown a 5.06% gain, while its one-month performance reflects an increase of 8.52%. Impressively, the stock has surged by 328.12% over the past year, significantly outperforming the China Shanghai Composite's 18.87% growth. Year-to-date, the stock has risen by 165.42%, compared to the composite's 3.16%. Despite these notable gains, the company faces challenges in management efficiency, with a low Return on Capital Employed (ROCE) of 9.64%. Additionally, the company has reported negative results for the last seven consecutive quarters, with a decline in net sales and operating profit over the past five years. The current market capitalization stands at CNY 19,342 million, reflecting its large-cap status in the packaging industry.